Chemed Company Profile (NYSE:CHE)

About Chemed

Chemed logoChemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS segment provides hospice care to Medicare beneficiaries receiving their non-hospice healthcare services from health maintenance organizations (HMOs) under Medicare risk contracts. The Company and its subsidiaries also own training manuals, cost information, patient information and software source codes. A portion of its VITAS business is operated in the state of Florida. The Company's Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: CHE
  • CUSIP: 16359R10
Key Metrics:
  • Previous Close: $178.81
  • 50 Day Moving Average: $168.59
  • 200 Day Moving Average: $149.94
  • 52-Week Range: $16,205,000.00 - $124.78
  • Trailing P/E Ratio: 27.59
  • Foreward P/E Ratio: 21.21
  • P/E Growth: 2.25
  • Market Cap: $2.90B
  • Outstanding Shares: 16,205,000
  • Beta: 1.21
  • Net Margins: 6.77%
  • Return on Equity: 23.95%
  • Return on Assets: 13.59%
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 0.79%
  • Quick Ratio: 0.76%
Additional Links:
Companies Related to Chemed:

Analyst Ratings

Consensus Ratings for Chemed (NYSE:CHE) (?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $150.33 (15.93% downside)

Analysts' Ratings History for Chemed (NYSE:CHE)
DateFirmActionRatingPrice TargetDetails
11/1/2016RBC Capital MarketsReiterated RatingSector Perform$162.00 -> $148.00View Rating Details
11/1/2016Royal Bank of CanadaLower Price TargetSector Perform$162.00 -> $148.00View Rating Details
9/27/2016Oppenheimer Holdings, Inc.Reiterated RatingOutperform$155.00View Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldView Rating Details
9/15/2015Deutsche Bank AGReiterated RatingBuyView Rating Details
(Data available from 2/27/2015 forward)


Earnings History for Chemed (NYSE:CHE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.44$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.69$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.51$1.48$360.00 million$358.40 millionViewListenView Earnings Details
7/23/2014Q214$1.47$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.32$1.32$256.77 million$358.30 millionViewListenView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Chemed (NYSE:CHE)
Current Year EPS Consensus Estimate: $7.90 EPS
Next Year EPS Consensus Estimate: $8.43 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$1.58$1.58$1.58
Q2 20161$1.74$1.74$1.74
Q3 20161$1.80$1.80$1.80
Q4 20161$2.08$2.08$2.08
Q1 20171$1.77$1.77$1.77
Q2 20171$1.89$1.89$1.89
Q3 20171$1.96$1.96$1.96
Q4 20171$2.31$2.31$2.31
Q1 20181$1.92$1.92$1.92
Q2 20181$2.03$2.03$2.03
Q3 20181$2.09$2.09$2.09
Q4 20181$2.42$2.42$2.42
(Data provided by Zacks Investment Research)


Current Dividend Information for Chemed (NYSE:CHE)
Annual Dividend:$1.04
Dividend Yield:0.58%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:16.59% (Based on Trailing 12 Months of Earnings)
13.16% (Based on Current Year Consensus EPS Estimate)
12.34% (Based on Next Year Consensus EPS Estimate)
Track Record:8 Years of Consecutive Dividend Growth

Dividend History for Chemed (NYSE:CHE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Chemed (NYSE:CHE)
Insider Ownership Percentage: 5.32%
Institutional Ownership Percentage: 99.72%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.00View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.00View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.00View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.00View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.00View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.00View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.32View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Chemed (NYSE:CHE)
DateHeadline logoChemed Corp. :CHE-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017 (NYSE:CHE) - February 22 at 4:26 PM logoCHEMED CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K) (NYSE:CHE) - February 19 at 4:00 PM logoEdited Transcript of CHE earnings conference call or presentation 16-Feb-17 3:00pm GMT (NYSE:CHE) - February 17 at 5:56 PM logoChemed Corp. :CHE-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017 (NYSE:CHE) - February 17 at 5:56 PM logoCHEMED CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (NYSE:CHE) - February 17 at 5:56 PM logoChemed : posts 4Q profit (NYSE:CHE) - February 16 at 9:22 PM logoChemed : posts 4Q profit (NYSE:CHE) - February 16 at 9:22 PM
News IconIs Chemed Corporation’s (CHE) ROE Of 21.8% Sustainable? (NYSE:CHE) - February 16 at 4:22 PM logoChemed Corporation (CHE) Reports In-Line Q4 EPS (NYSE:CHE) - February 16 at 4:22 PM logoChemed Corp. Profit Climbs 2% In Q4 (NYSE:CHE) - February 16 at 4:22 PM logoChemed's (CHE) CEO Kevin McNamara on Q4 2016 Results - Earnings Call Transcript (NYSE:CHE) - February 16 at 4:22 PM logoBRIEF-Chemed Q4 GAAP earnings per share $1.94 (NYSE:CHE) - February 16 at 4:22 PM logoChemed Corp Earnings Call scheduled for 10:00 am ET today (NYSE:CHE) - February 16 at 4:22 PM logoChemed Corporation to Present at the 2017 RBC Capital Markets’ Global Healthcare Conference (NYSE:CHE) - February 16 at 4:22 PM logoQ4 2016 Chemed Corp Earnings Release - After Market Close (NYSE:CHE) - February 16 at 9:55 AM logoChemed Reports Fourth-Quarter 2016 Results (NYSE:CHE) - February 16 at 9:55 AM logo4:19 pm Chemed beats by $0.03, misses on revs; guides FY17 EPS above consensus (NYSE:CHE) - February 16 at 9:55 AM logoCHEMED CORP Files SEC form 8-K, Results of Operations and Financial Condition (NYSE:CHE) - February 16 at 9:55 AM logoChemed posts 4Q profit (NYSE:CHE) - February 16 at 9:55 AM
News IconAs T Rowe Price Group INC (TROW) Market Value Declined, Holder Btim Corp Has Cut Holding by $10.68 Million (NYSE:CHE) - January 26 at 5:09 PM
News IconChemed - Chart Of The Day (NYSE:CHE) - January 20 at 10:27 PM logoChemed To Report Fourth-Quarter 2016 Earnings February 15, Related Conference Call To Be Held On February 16 (NYSE:CHE) - January 20 at 5:25 PM logoETFs with exposure to Chemed Corp. : December 21, 2016 (NYSE:CHE) - December 21 at 4:58 PM
News IconHospice provider says lawsuit involving Fata settled to avoid legal fees, not admit wrongdoing (NYSE:CHE) - December 1 at 9:26 PM
News IconInsider Worth Mentioning: Chemed Corporation (NYSE:CHE)’s Stock Insider Trade – Donald Saunders Sells 500 Shares (NYSE:CHE) - November 15 at 10:27 PM logoETFs with exposure to Chemed Corp. : November 14, 2016 (NYSE:CHE) - November 14 at 4:22 PM logoChemed Corp. :CHE-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016 (NYSE:CHE) - November 10 at 11:28 AM logoEx-Dividend Reminder: Eli Lilly, Teleflex and Chemed (NYSE:CHE) - November 9 at 12:06 PM logoChemed Corporation Declares Quarterly Dividend of 26 Cents (NYSE:CHE) - November 4 at 12:53 PM
News IconInsider Market Move: Kevin Mcnamara, president and CEO of Chemed Corporation (NYSE:CHE) Just Unloaded Shares (NYSE:CHE) - November 1 at 4:16 PM logoChemed Corporation to Present at the 2016 Credit Suisse Healthcare Conference (NYSE:CHE) - November 1 at 4:16 PM logoCHEMED CORP Files SEC form 10-Q, Quarterly Report (NYSE:CHE) - November 1 at 8:20 AM logoChemed (CHE) Lags Q3 Earnings, Tops Sales; EPS View Up (NYSE:CHE) - October 28 at 3:56 PM logoChemed : posts 3Q profit (NYSE:CHE) - October 28 at 8:36 AM logoChemed Reports Third-Quarter 2016 Results (NYSE:CHE) - October 28 at 8:36 AM logoChemed's (CHE) CEO Kevin McNamara on Q3 2016 Results - Earnings Call Transcript (NYSE:CHE) - October 28 at 8:36 AM logoEdited Transcript of CHE earnings conference call or presentation 27-Oct-16 2:00pm GMT (NYSE:CHE) - October 28 at 8:36 AM logoChemed posts 3Q profit (NYSE:CHE) - October 27 at 8:42 AM logoChemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : October 27, 2016 (NYSE:CHE) - October 27 at 8:42 AM logoHealthcare Earnings to Watch on Oct 26: UHS, WOOF, CHE, PRXL (NYSE:CHE) - October 25 at 9:01 AM
News IconUpdate on Chemed Corp. (NYSE:CHE) for the day (NYSE:CHE) - October 15 at 9:01 AM
News IconTop Performer of the day: Washington Real Estate Investment Trust (NYSE:WRE) (NYSE:CHE) - October 13 at 8:34 AM logoChemed To Report Third-Quarter 2016 Earnings October 26, Related Conference Call To Be Held On October 27 (NYSE:CHE) - October 7 at 9:05 AM logoGlobal Home Healthcare Market Outlook: 2016-2022 (NYSE:CHE) - September 30 at 9:14 AM
News Iconexecutive vice president of Chemed Corp (NYSE:CHE), Lee Spencer S, sells 2,000 shares worth $283,340 (NYSE:CHE) - September 24 at 8:26 AM logoChemed Corp. – Value Analysis (NYSE:CHE) : September 12, 2016 (NYSE:CHE) - September 12 at 4:02 PM logoChemed Corp. breached its 50 day moving average in a Bullish Manner : CHE-US : September 9, 2016 (NYSE:CHE) - September 9 at 9:02 AM logoCHE Makes Bullish Cross Above Critical Moving Average (NYSE:CHE) - September 8 at 5:43 AM logoChemed Corporation to Present at the Morgan Stanley Global Healthcare Conference (NYSE:CHE) - September 7 at 8:39 AM logoChemed is Now Oversold (CHE) (NYSE:CHE) - August 19 at 11:55 AM


What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, February 17th. Stockholders of record on Monday, February 27th will be given a dividend of $0.26 per share on Monday, March 20th. This represents a $1.04 annualized dividend and a dividend yield of 0.58%. The ex-dividend date of this dividend is Thursday, February 23rd.

Where is Chemed's stock going? Where will Chemed's stock price be in 2017?

4 analysts have issued 1 year target prices for Chemed's stock. Their predictions range from $148.00 to $155.00. On average, they expect Chemed's share price to reach $150.33 in the next twelve months.

When will Chemed announce their earnings?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

Who owns Chemed stock?

Chemed's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (5.27%), Gamco Investors INC. ET AL (3.86%), Shelton Capital Management (3.08%), Investec Asset Management LTD (2.64%), State Street Corp (2.52%) and Dimensional Fund Advisors LP (2.42%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace, Spencer S Lee and Timothy S Otoole.

Who sold Chemed stock? Who is selling Chemed stock?

Chemed's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, Two Sigma Investments LP, Renaissance Technologies LLC, Fiera Capital Corp, Royce & Associates LP, Gamco Investors INC. ET AL, Guggenheim Capital LLC and AQR Capital Management LLC. Company insiders that have sold Chemed stock in the last year include Arthur V Tucker Jr, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee.

Who bought Chemed stock? Who is buying Chemed stock?

Chemed's stock was bought by a variety of institutional investors in the last quarter, including Shelton Capital Management, Russell Investments Group Ltd., Thrivent Financial for Lutherans, Cardinal Capital Management LLC CT, FMR LLC, State Street Corp, Employees Retirement System of Texas and DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main.

How do I buy Chemed stock?

Shares of Chemed can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Chemed stock cost?

One share of Chemed stock can currently be purchased for approximately $178.81.

Chemed (NYSE:CHE) Chart for Monday, February, 27, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Earnings History Chart

Earnings by Quarter for Chemed (NYSE:CHE)

Dividend History Chart

Dividend Payments by Quarter for Chemed (NYSE:CHE)

Last Updated on 2/27/2017 by Staff